Cognition in Schizophrenia: Impairments, Determinants, and Functional Importance

Bowie, Christopher R., Harvey, Philip D.·2005·Psychiatric Clinics of North America

Cited by (280)

Items 101–200 of 280

  1. Neurocognitive function in schizophrenia with comorbid posttraumatic stress disorder
    Lisa A. Duke, Daniel N. Allen, Sylvia Ross, Gregory P. Strauss, Jason Schwartz · 2010 · Journal of Clinical and Experimental Neuropsychology
  2. Pharmacological Augmentation of Psychosocial and Remediation Training Efforts in Schizophrenia
    Philip D. Harvey, Michael S. Sand · 2017 · Frontiers in Psychiatry
  3. Potential role of adenosine A2A receptors in the treatment of schizophrenia.
    J. Wardas · 2008 · Frontiers in Bioscience
  4. Preserved, deteriorated, and premorbidly impaired patterns of intellectual ability in schizophrenia.
    Narmeen Ammari, R. Walter Heinrichs, Farena Pinnock, Ashley A. Miles, Eva Muharib, Stephanie McDermid Vaz · 2014 · Neuropsychology
  5. Asperger Syndrome and Schizophrenia: A Comparative Neuropsychological Study
    Maria Marinopoulou, Tove Lugnegård, Maria Unenge Hallerbäck, Christopher Gillberg, Eva Billstedt · 2016 · Journal of Autism and Developmental Disorders
  6. The course of vocational functioning in patients with schizophrenia: Re-examining social drift
    Gabriela Vargas, Martin Strassnig, Samir A. Sabbag, Felicia Gould, Dante Durand, Laura Stone, Thomas L. Patterson, Philip D. Harvey · 2014 · Schizophrenia Research Cognition
  7. Neurocognition and occupational functioning in schizophrenia spectrum disorders: The MATRICS Consensus Cognitive Battery (MCCB) and workplace assessments
    June Ullevoldsæter Lystad, Erik Falkum, Vegard Øksendal Haaland, Helen Christine Bull, Stig Evensen, Morris David Bell, Torill Ueland · 2015 · Schizophrenia Research
  8. Schizophrenia in a Patient With Spinocerebellar Ataxia 2: Coincidence of Two Disorders or a Neurodegenerative Disease Presenting With Psychosis?
    Matthew Rottnek, Silvana Riggio, William M. Byne, Mary C. Sano, Russell L. Margolis, Ruth Helen Walker · 2008 · American Journal of Psychiatry
  9. The Schizophrenia Spectrum Personality Disorders
    Erán Chemerinski, Larry J. Siever · 2010 · Wiley eBooks
  10. A neural efficiency-threshold model to understand psychotic experiences
    Ian Kelleher, Mary D Cannon · 2021 · Psychological Medicine
  11. Managing psychiatric disorders with antidiabetic agents: translational research and treatment opportunities
    Roger S. McIntyre, Joanna K. Soczynska, Gary F. Lewis, GLENDA M. MacQUEEN, Jakub Z. Konarski, Sidney H. Kennedy · 2006 · Expert Opinion on Pharmacotherapy
  12. Implementing cognitive remediation and social cognitive interaction training into standard psychosis care
    Frances Louise Dark, Meredith Harris, Victoria Gore‐Jones, Ellie Newman, Harvey Whiteford · 2018 · BMC Health Services Research
  13. Blonanserin versus haloperidol in Japanese patients with schizophrenia: A phase 3, 8‐week, double‐blind, multicenter, randomized controlled study
    Philip D. Harvey, Hiroshi Nakamura, Mitsukuni Murasaki · 2019 · Neuropsychopharmacology Reports
  14. Verbal memory performance predicts remission and functional outcome in people at clinical high-risk for psychosis
    Emily P. Hedges, Hannah Dickson, Stefania Tognin, Gemma Modinos, Mathilde Antoniades, Mark van der Gaag, Lieuwe de Haan, Patrick D. McGorry, Christos Pantelis, Anita Riecher‐Rössler et al. · 2021 · Schizophrenia Research Cognition
  15. A proton magnetic resonance spectroscopy study in schizoaffective disorder: Comparison of bipolar disorder and schziophrenia
    Demet Kalaycı, Osman İsmail Özdel, Gülfizar Sözeri Varma, Yılmaz Kıroğlu, Selim Tümkaya · 2012 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  16. Understanding the lived experience of cognitive remediation in schizophrenia: A qualitative comparison with an active control.
    Shayden Bryce, Narelle Warren, Jennie Louise Ponsford, Susan Lee Rossell, Stuart J. Lee · 2018 · Psychiatric Rehabilitation Journal
  17. Ecological Assessments of Activities of Daily Living and Personal Experiences with Mobus, An Assistive Technology for Cognition: A Pilot Study in Schizophrenia
    Juliette Sablier, Émmanuel Stip, Pierre O. Jacquet, Sylvain Giroux, Hélène Pigot, Mobus group, Nicolas Franck B · 2012 · Assistive Technology
  18. Patterns of association between performance in a natural environment and measures of executive function in people with schizophrenia
    Elizabeth Zayat, Melisa V. Rempfer, Byron J. Gajewski, Catana E. Brown · 2010 · Psychiatry Research
  19. The overlap of cognitive impairment in depression and schizophrenia: a comparative study.
    Mojca Šoštarič Zvonar, Bojan Zalar · 2011 · PubMed
  20. Associating functional recovery with neurocognitive profiles identified using partially ordered classification models
    Judith Jaeger, Curtis M. Tatsuoka, Stefanie M. Berns, F. Váradi, Pál Czobor, Sarah Uzelac · 2006 · Schizophrenia Research
  21. Diabetes and Cognitive Deficits in Chronic Schizophrenia: A Case-Control Study
    Mei Han, Xu‐Feng Huang, Da Chun Chen, Meihong Xiu, Thomas R. Kosten, Xiang Yang Zhang · 2013 · PLoS ONE
  22. Cross-diagnostic determinants of cognitive functioning: the muscarinic cholinergic receptor as a model system
    Sara E. Jones, Philip D. Harvey · 2023 · Translational Psychiatry
  23. Simulation of the capacity and precision of working memory in the hypodopaminergic state: Relevance to schizophrenia
    Tsukasa Okimura, Shoji Tanaka, T. Maeda, Masaru Kato, Masaru Mimura · 2015 · Neuroscience
  24. A symptom-based continuum of psychosis explains cognitive and real-world functional deficits better than traditional diagnoses
    Faith M. Hanlon, Ronald A. Yeo, Nicholas A. Shaff, Christopher J. Wertz, Andrew B. Dodd, Juan Bustillo, Shannon F. Stromberg, Denise S. Lin, Swala K. Abrams, Jingyu Liu et al. · 2019 · Schizophrenia Research
  25. Ageing with schizophrenia: an update
    Haley V. Solomon, Martina Sinopoli, Lynn E. DeLisi · 2021 · Current Opinion in Psychiatry
  26. Deficits in Neurocognition, Theory of Mind, and Social Functioning in Patients With Schizophrenic Disorders
    Maryse Badan Bâ, Adriano Zanello, Marion Varnier, Vanessa Koellner, Marco C.G. Merlo · 2008 · The Journal of Nervous and Mental Disease
  27. Executive function in schizophrenia: Influence of substance use disorder history
    Roberto Rodríguez–Jiménez, Alexandra Bagney, Isabel Martínez‐Gras, Guillermo Ponce, Eva María Sánchez‐Morla, María Aragüés, Gabriel Rubio, Miguel Ángel Jiménez‐Arriero, José Luis Santos, Tomás Palomo · 2009 · Schizophrenia Research
  28. Associations of NEUROD2 polymorphisms and change of cognitive dysfunctions in schizophrenia and schizoaffective disorder after eight weeks of antipsychotic treatment
    Ilja Spellmann, Michael J Riedel, Julia Städtler, Peter Zill, Michael Obermeier, Anja Cerovecki, Sandra Dehning, Rebecca Schennach, Maria Epple, Markus Opgen-Rhein et al. · 2017 · Cognitive Neuropsychiatry
  29. Schizophrenia from a neuropsychiatric perspective.
    Christopher R. Bowie, Philip D. Harvey · 2006 · PubMed
  30. The Relationship between Language Ability and Cognitive Function in Patients with Schizophrenia
    Sung-Jin Kim, Joo-Cheol Shim, Bo-Geum Kong, Je-Wook Kang, Jung‐Joon Moon, Dong-Wook Jeon, Sung Soo Jung, Beom-Joo Seo, Do-Un Jung · 2015 · Clinical Psychopharmacology and Neuroscience
  31. Efficacy of Risperidone Augmentation with Ondansetron in the Treatment of Negative and Depressive Symptoms in Schizophrenia: A Randomized Clinical Trial.
    Roya Samadi, Susan Soluti, Reza Daneshmand, Shervin Assari, Ali Akhoundpour Manteghi · 2017 · PubMed Central
  32. Subtle Cognitive Dysfunction in Nonaffected Siblings of Individuals Affected by Nonpsychotic Disorders
    Mark Weiser, Abraham Reichenberg, Efrat Kravitz, Gadi Lubin, Moti Shmushkevich, David C. Glahn, Raz Gross, Jonathan Rabinowitz, Shlomo Noy, Michael Davidson · 2007 · Biological Psychiatry
  33. Randomized controlled trial of social cognition and interaction training compared to befriending group
    Frances Louise Dark, James G. Scott, Andrea Baker, Stephen Parker, Anne Gordon, Ellie Newman, Victoria Gore‐Jones, Carmen C. W. Lim, Lyndall Jones, David L. Penn · 2020 · British Journal of Clinical Psychology
  34. Cognitive performance, symptom severity, and survival among patients with schizophrenia spectrum disorder: A prospective 15-year study
    Lars Helldin, Fredrik Hjärthag, Anna-Karin Olsson, Philip D. Harvey · 2015 · Schizophrenia Research
  35. Antipsychotic-induced parkinsonism is associated with working memory deficits in schizophrenia-spectrum disorders
    Stéphane Potvin, Ginette Aubin, Émmanuel Stip · 2014 · European Archives of Psychiatry and Clinical Neuroscience
  36. A Case of Olanzapine-Induced Gestational Diabetes Mellitus in the Absence of Weight Gain
    Mytilee Vemuri, Natalie Rasgon · 2007 · The Journal of Clinical Psychiatry
  37. Cognition sociale dans la schizophrénie et les troubles du spectre de l’autisme : points de convergences et différences fonctionnelles
    E. Le Gall, Galina Iakimova · 2018 · L Encéphale
  38. Ziprasidone-induced cognitive enhancement in schizophrenia: Specificity or pseudospecificity?
    Anil K. Malhotra, Katherine E. Burdick, Kamran Razi, John A. Bates, Michael Sanders, John Michael Kane · 2006 · Schizophrenia Research
  39. Schizophrenia Susceptibility Genes: in Search of A Molecular Logic and Novel Drug Targets for A Devastating Disorder
    Joseph A. Gogos · 2007 · International review of neurobiology
  40. The relationship between Positive and Negative Syndrome Scale (PANSS) schizophrenia severity scores and risk for hospitalization: An analysis of the CATIE Schizophrenia Trial
    Henry A. Glick, Pengxiang Li, Philip D. Harvey · 2015 · Schizophrenia Research
  41. Social Functioning in Schizophrenia Clinical Correlations.
    Mircea Mihai Duţescu, Raluca Popescu, L Balcu, Lavinia Corina DUICA, Livia Mihaela Strunoiu, D Alexandru, Mihail Cristian Pîrlog · 2018 · Europe PMC (PubMed Central)
  42. Barriers to the Appropriate Clinical Use of Medications That Improve the Cognitive Deficits of Schizophrenia
    Elizabeth Bromley · 2007 · Psychiatric Services
  43. A comparison of regional brain volumes and white matter connectivity in subjects with stimulant induced psychosis versus schizophrenia
    Peter D. Alexander, Kristina M. Gicas, Alex Cheng, Donna J. Lang, Ric M. Procyshyn, Alexandra Talia Vertinsky, William J. Panenka, Allen E. Thornton, Alexander Rauscher, Jamie Y. X. Wong et al. · 2019 · Psychopharmacology
  44. Cognitive functioning and negative symptoms in first episode schizophrenia: Different patterns of correlates
    José Manuel Rodríguez-Sánchez, Benedicto Crespo‐Facorro, César González‐Blanch, Rocío Pérez‐Iglesias, Mario Álvarez‐Jiménez, Obdulia Martínez, José Luis Vázquez‐Barquero · 2008 · Neurotoxicity Research
  45. Cognitive deficits, obesity and disability in schizophrenia
    Martin Strassnig, Ricardo Cáceda, John W. Newcomer, Philip D. Harvey · 2012 · Translational Neuroscience
  46. Sleep, sleep spindles, and cognitive functions in drug-naive patients with first-episode psychosis
    Nakşidil Yazıhan, Si̇nan Yetki̇n · 2020 · Journal of Clinical Sleep Medicine
  47. Déficit cognitivo en la esquizofrenia: MATRICS Consensus Cognitive Battery
    Roberto Rodríguez–Jiménez, Alexandra Bagney, Marta Moreno-Ortega, Cristina García-Navarro, Ana Isabel Aparicio, Raúl López‐Antón, Jose de la Oliva, Miguel Ángel Jiménez Arriero, José Luis Santos, António Lobo et al. · 2012 · Revista de Neurología
  48. Conflict adaptation in schizophrenia: reviewing past and previewing future efforts
    Elger L. Abrahamse, Marit F. L. Ruitenberg, Wout Duthoo, Bernard Sabbe, Manuel Morrens, Jean‐Philippe van Dijck · 2016 · Cognitive Neuropsychiatry
  49. Pharmacogenetic tools for the development of target-oriented cognitive-enhancing drugs
    Jose A. Apud, Daniel R. Weinberger · 2006 · NeuroRx
  50. Neuropsychologische Modelle von Autismus-Spektrum-Störungen
    Isabel Dziobek, Sven Bölte · 2011 · Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie
  51. Differentiating cortical patterns of cognitive dysfunction in schizophrenia and posttraumatic stress disorder
    Cherrie Ann Galletly, ALEXANDER COWELL McFARLANE, Christopher R. Clark · 2008 · Psychiatry Research
  52. Functional profile of mental health consumers assessed by occupational therapists: Level of independence and associations with functional cognition
    Justin Newton Scanlan, Megan Still · 2013 · Psychiatry Research
  53. Reduction in perseverative errors with adjunctive ethyl-eicosapentaenoic acid in patients with schizophrenia: Preliminary study
    Ravinder K. Reddy, Sara Fleet Michaliszyn, Ruth Condray, J.K. Yao, Matcheri S. Keshavan, Ravinder D Reddy · 2011 · Prostaglandins Leukotrienes and Essential Fatty Acids
  54. Neuropsychological performance as endophenotypes in extended schizophrenia families from the Central Valley of Costa Rica
    Hilary C. Bertisch, Andrea Mesén, Maureen V. Martin, Vanessa Pérez-Vargas, Tatiana Vargas-Rodríguez, Gabriela Delgado, Camila Delgado, Michele Llach, Beatrice LaPrade, William Byerley et al. · 2008 · Psychiatric Genetics
  55. The Psychosis Recent Onset GRoningen Survey (PROGR-S): Defining Dimensions and Improving Outcomes in Early Psychosis
    Edith Jantine Liemburg, Stynke Castelein, Frank van Es, Anne Neeltje Scholte-Stalenhoef, G. van de Willige, Henderikus G. O. M. Smid, Ellen Visser, Henderikus Knegtering, Richard Bruggeman · 2014 · PLoS ONE
  56. Antipsychotic medication-mediated cognitive change in schizophrenia and polygenic score for cognitive ability
    Rachael Keir Blackman, Dwight Dickinson, Daniel Paul Eisenberg, Michael D. Gregory, Jose A. Apud, Karen Faith Berman · 2021 · Schizophrenia Research Cognition
  57. Neurocognition, functional competence and self-reported functional impairment in psychometrically defined schizotypy
    Shannon Xavier, Michael W. Best, Emily Schorr, Christopher R. Bowie · 2014 · Cognitive Neuropsychiatry
  58. Distinct conflict resolution deficits related to different facets of Schizophrenia
    John G. Kerns · 2008 · Psychological Research
  59. Shifted neuronal balance during stimulus–response integration in schizophrenia: an fMRI study
    Edna C. Cieslik, Veronika I. Müller, Tanja S. Kellermann, Christian Grefkes, Sarah Halfter, Simon Bodo Eickhoff · 2013 · Brain Structure and Function
  60. In silico hippocampal modeling for multi-target pharmacotherapy in schizophrenia
    Mohamed A. Sherif, Samuel A. Neymotin, William W. Lytton · 2020 · Schizophrenia
  61. Rehabilitación cognitiva en la esquizofrenia: estado actual y perspectivas futuras
    Jesús de la Higuera Romero, Eneka Sagastagoitia Ruiz · 2006 · APUNTES DE PSICOLOGÍA
  62. Altered brainstem responses to modafinil in schizophrenia: implications for adjunctive treatment of cognition
    Michael Minzenberg, Jong H. Yoon, Steffan K. Soosman, Cameron S. Carter · 2018 · Translational Psychiatry
  63. Absence of established sex differences in patients with schizophrenia on a two-dimensional object array task
    Seth L. Shipman, Elizabeth K. Baker, Godfrey D. Pearlson, Robert S. Astur · 2009 · Psychiatry Research
  64. Clinical effectiveness of metacognitive training as a transdiagnostic program in routine clinical settings: A prospective, multicenter, single‐group study
    Hiroki Tanoue, Naoki Yoshinaga, Yuta Hayashi, Ryotaro Ishikawa, Takuma Ishigaki, Yasushi Ishida · 2020 · Japan Journal of Nursing Science
  65. Similarities and differences between multivariate patterns of cognitive and socio-cognitive deficits in schizophrenia, bipolar disorder and related risk
    Alessandra Raio, Giulio Pergola, Antonio Rampino, Marianna Russo, Enrico D’Ambrosio, Pierluigi Selvaggi, Valerie De Chiara, Mario Altamura, Flora Brudaglio, Alessandro Saponaro et al. · 2023 · Schizophrenia
  66. Circadian lighting effect for inpatients with schizophrenia: A prospective cohort study
    Ya‐Chi Tsai, Jwo‐Huei Jou, Ching‐Chi Hsu, Ming‐Chang Shih, Luke The, Dipanshu Sharma · 2024 · Brain and Behavior
  67. Diagnostic Accuracy of a New Instrument for Detecting Cognitive Dysfunction in an Emergent Psychiatric Population: The Brief Cognitive Screen
    Steven P. Cercy, Zoya Simakhodskaya, Aaron Elliott · 2010 · Academic Emergency Medicine
  68. Cognitive neurosciences: A new paradigm in management and outcome of schizophrenia
    Amresh Shrivastava, Megan Johnston · 2010 · Indian Journal of Psychiatry
  69. Prospective memory impairments in schizophrenic patients.
    Imanollah Bigdeli, Azin Farzin, Siavosh Talepasand · 2014 · PubMed Central
  70. Discrimination within Recognition Memory in Schizophrenia
    Kathryn A. McGuire, Melanie Blahnik, Scott R. Sponheim · 2013 · Behavioral Sciences
  71. The Neurobiology of Schizophrenia
    William Victor Bobo, Judith L. Rapoport, Anissa Abi‐Dargham, S. Hossein Fatemi, Herbert Y. Meltzer · 2015 · Wiley eBooks
  72. Technologie et Alzheimer : appréciation de la faisabilité de la mise en place de technologies innovantes pour assister les aidants familiaux et pallier les pathologies de type Alzheimer
    Vincent Rialle · 2007 · HAL
  73. Gray matter matters: Cognitive stability and flexibility in schizophrenia spectrum disorder
    Florentine Herkströter, Anoushiravan Zahedi, Isabel Standke, Udo Dannlowski, Rebekka Lencer, Ricarda Ines Schubotz, Ima Trempler · 2024 · Psychophysiology
  74. Neurocognitive and social cognitive correlates of social exclusion in psychotic disorders: a 20-year follow-up cohort study
    Víctor Peralta, Ana Maria Sánchez-Torres, Gustavo J. Gil‐Berrozpe, Elena García de Jalón, Lucía Moreno-Izco, David Peralta, Lucía Janda, Manuel Jesús Cuesta, SEGPEPs group, A. Ballesteros et al. · 2024 · Social Psychiatry and Psychiatric Epidemiology
  75. Cognitive Effects of Reducing First-Generation Antipsychotic Dose Compared to Switching to Ziprasidone in Long-Stay Patients with Schizophrenia
    Jan P.A.M. Bogers, Jasper A. Blömer, Lieuwe de Haan · 2024 · Journal of Clinical Medicine
  76. Where are patients who have co-occurring mental and physical diseases located?
    Kristian L. Toftegaard, Lea Nørgreen Gustafsson, Richard Uwakwe, Ulla Agerskov Andersen, Thomas M Becker, Graziella Giacometti Bickel, Bernhard Bork, Joachim Cordes, Karel Frasch, Bent Ascanius Jacobsen et al. · 2014 · International Journal of Social Psychiatry
  77. Evaluating how treatment adherence influences cognitive remediation outcomes
    Benedetta Seccomandi, Deborah Agbedjro, Richard S.E. Keefe, Silvana Galderisi, Joanna M. Fiszdon, Armida Mucci, Til Wykes, Matteo Cella · 2022 · Behaviour Research and Therapy
  78. Cognitive aspects of schizophrenia
    Philip D. Harvey · 2013 · Wiley Interdisciplinary Reviews Cognitive Science
  79. Can small molecules provide truly effective enhancement of cognition? Current achievements and future directions
    Niels Plath, Linda Lerdrup, Peter Hjørringgaard Larsen, John Paul Redrobe · 2011 · Expert Opinion on Investigational Drugs
  80. Age at Onset and Social Cognitive Impairment in Clinically Stabilized Patients with Schizophrenia: An Ecological Cross-Sectional Study.
    Alice Caldiroli, Marta Serati, Giulia Orsenigo, Elisabetta Caletti, Massimiliano Buoli · 2018 · Europe PMC (PubMed Central)
  81. Evolution of the human CNS cholineric system: has this resulted in the emergence of psychiatric disease?
    Brian Dean · 2009 · Australian & New Zealand Journal of Psychiatry
  82. Is game-based therapy effective for treating cognitive deficits in adults with schizophrenia? Evidence from a randomized controlled trial
    Junkai Wang, Jie Zhang, Peng Hui Xu, Tianyi Qian, Shuping Tan, Peipeng Liang · 2024 · Translational Psychiatry
  83. Spatial behavior reflects the mental disorder in OCD patients with and without comorbid schizophrenia
    Anat Gershoni, Haggai Hermesh, Naomi Anne Fineberg, David Eilam · 2013 · CNS Spectrums
  84. Investigating the Robustness of a Rodent “Double Hit” (Post-Weaning Social Isolation and NMDA Receptor Antagonist) Model as an Animal Model for Schizophrenia: A Systematic Review
    Khanyiso Bright Shangase, Mluleki Luvuno, Musa Vuyisile Mabandla · 2023 · Brain Sciences
  85. Recovery from Schizophrenia: A Four-year Study of an Inner City Cohort
    Marina P. Economou, Alexandra Palli, Lily Εvangelia Peppou, Michael G. Madianos · 2011 · Community Mental Health Journal
  86. Neurological soft signs in Chinese adolescents with schizophrenia and schizotypal personality traits
    Xin Wang, Lin Cai, Lingyan Li, Yanjie Yang, Xiongzhao Zhu · 2016 · International Journal of Developmental Neuroscience
  87. A feasibility, randomised controlled trial of Club Connect: a group-based healthy brain ageing cognitive training program for older adults with major depression within an older people’s mental health service
    Claudia Woolf, L. Kaplan, Louisa Margaret Norrie, D. Burke, Michelle M. Cunich, Loren Mowszowski, Sharon Linda Naismith · 2024 · BMC Psychiatry
  88. Performance on the Cognitive Estimation Test in Schizophrenia
    Robert M. Roth, Heather S. Pixley, Carrie L. Kruck, Matthew A. Garlinghouse, Peter R. Giancola, Laura A. Flashman · 2012 · Applied Neuropsychology Adult
  89. Time-Dependent Alterations in the Expression of NMDA Receptor Subunits along the Dorsoventral Hippocampal Axis in an Animal Model of Nascent Psychosis
    Valentyna Dubovyk, Denise Manahan‐Vaughan · 2018 · ACS Chemical Neuroscience
  90. Neuroimaging predictors of response to cognitive remediation and social skills training: A pilot study in veterans with schizophrenia
    Margaret McNamara McClure, Fiona S. Graff, Joseph Triebwasser, M. Mercedes Pérez-Rodríguez, Daniel R. Rosell, Philip R. Szeszko, King-Wai Chu, Antonia S. New, Larry J. Siever, Erin A. Hazlett · 2019 · Psychiatry Research Neuroimaging
  91. Efficacy of Social Skills Training in Schizophrenia: A Nursing Review
    Babu Lal Yadav · 2015 · Lenus, The Irish Health Repository (Dr Steevens Hospital Library)
  92. The quest for developing new treatments from imaging techniques: promises, problems and future potential
    Michael Minzenberg, Cameron S. Carter · 2007 · Expert Opinion on Drug Discovery
  93. Altered expression and alpha‐1 adrenergic receptor mediated activity of protein kinase C in the prefrontal cortex of rats with neonatal ventral hippocampus lesions
    Irina Al‐Khairi, Moogeh Baharnoori, Aarthi Kamath, Sanjeev K. Bhardwaj, Lalit K. Srivastava · 2009 · Synapse
  94. Alterations of serum neuropeptide levels and their relationship to cognitive impairment and psychopathology in male patients with chronic schizophrenia
    Wenxi Sun, Tingting Jin, Haidong Yang, Jin Li, Qing Tian, Ju Gao, Ruijie Peng, Guangya Zhang, Xiaobin Zhang · 2024 · Schizophrenia
  95. Bir Toplum Ruh Sağlığı Merkezindeki Beceri Eğitimlerinin Günlük Yaşam Aktiviteleri ve Bilişsel Fonksiyonlara Katkısı
    Gülçin Elboğa, Şengül Kocamer Şahin, Abdurrahman Altındağ · 2019 · Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry
  96. No association between cortical dopamine D2 receptor availability and cognition in antipsychotic-naive first-episode psychosis
    Maria Lee, Helena Fatouros‐Bergman, Pontus Plavén‐Sigray, Pauliina Ikonen Victorsson, Carl M. Sellgren, Sophie Erhardt, Lena Flyckt, Lars Farde, Simon Červenka · 2021 · Schizophrenia
  97. Distinct Time-Course of Alterations of Groups I and II Metabotropic Glutamate Receptor and GABAergic Receptor Expression Along the Dorsoventral Hippocampal Axis in an Animal Model of Psychosis
    Valentyna Dubovyk, Denise Manahan‐Vaughan · 2019 · Frontiers in Behavioral Neuroscience
  98. Les perturbations de la conscience dans la schizophrénie : évaluation du modèle de C.D. Frith
    Marc‐André Roy, M-A Roy, Simon Grondin · 2008 · L Encéphale
  99. Legal fallacies of antipsychotic drugs.
    Steven K. Erickson, J. Richard Ciccone, Steven B. Schwarzkopf, J. Steven Lamberti, Michael J. Vitacco · 2007 · PubMed
  100. Biomarkers in Schizophrenia
    A. Wong, L. Feldcamp · 2008 · Springer eBooks